Search Results 451-460 of 16377 for Break STD Taboo

1. General Internal Medicine - Clinical trials

   ... standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to ...

2. News - Christi A. Patten, Ph.D. - Mayo Clinic

   Christi A. Patten, Ph.D. Request an Appointment · Overview · News ...

3. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

   difficile infection (CDI) after a primary episode and have completed at least two rounds of standard-of-care oral antibiotic therapy or have had at least ...

4. Publications - David M. Nestler, M.D., M.S. - Mayo Clinic

   Enayati M, Zanjirani Farahani N, Nestler D, Heaton H, Pasupathy K. Can Real-Time Location System Replace Current Standard for Capture of Length of Stay? 2020 ...

5. Study Of Lurbinectedin In Combination With Doxorubicin Versus Doxorubicin Alone As First-line Treatment In Participants With Metastatic Leiomyosarcoma - Mayo Clinic

   ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

6. RBX2660 Administered by Colonoscopy for Recurrent Clostridioides difficile Infection - Mayo Clinic

   ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

7. An Extension Study Of Subjects Who Received An Avalyn Inhaled Antifibrotic Agent (SAIL) - Mayo Clinic

   In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the ...

8. HL7 2.5.1 Implementation Guide

   ... Standard, specification or other freely licensed work (in each and every instance "Specified Material"), the following describes the permitted uses of the ...

9. Breast cancer - Doctors and departments - Mayo Clinic

   ... standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to ...

10. Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia - Mayo Clinic

    Monoclonal antibodies, such as blinatumomab, may interfere with the ability of tumor cells to grow and spread. It is not yet known whether standard combination ...